⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Galen Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Galen Limited
↗Craigavon, United Kingdom
Galen Limited is a privately-owned pharmaceutical sales and marketing company headquartered in Craigavon, Northern Ireland. Established in 1968, it is a founding member of the Almac Group and is wholly owned by the McClay Foundation, which focuses on advancing human health. The company operates globally with a presence in the UK, Europe, and the Nordics, specializing in pain management, dermatology, gastroenterology, and medical nutrition.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical Sales and Marketing
SIZE & FINANCIALS
Employees:201-500
Founded:1968
Ownership:subsidiary
Status:operating
FUNDING
Investors:McClay Foundation
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Medical Nutrition
Active Trials:0
Trial Phases:-
FDA Approvals:0
CORPORATE STRUCTURE
Parent Company:Almac Group
Subsidiaries:POA Pharma Scandinavia AB, POA Pharma GmbH, Galen Pharma Ireland Limited
Key Partnerships:Istituto Gentili (Nordic distribution), Salvat (ENT portfolio), Almeda Pharmaceuticals AG
COMPETITION
Position:Niche Player
Competitors:Cardinal Health, CNX Therapeutics
LEADERSHIP
Key Executives:
Dr. Dennise Broderick - President and Managing Director
Simon Lawrence - Vice President of Marketing and Medical Nutrition
LINKS
Website:galen-pharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Galen Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.